0001209191-16-124799.txt : 20160601
0001209191-16-124799.hdr.sgml : 20160601
20160601185019
ACCESSION NUMBER: 0001209191-16-124799
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160601
FILED AS OF DATE: 20160601
DATE AS OF CHANGE: 20160601
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Clearside Biomedical, Inc.
CENTRAL INDEX KEY: 0001539029
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 452437375
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1220 OLD ALPHARETTA RD
STREET 2: SUITE 300
CITY: ALPHARETTA
STATE: GA
ZIP: 30005
BUSINESS PHONE: 678-270-4005
MAIL ADDRESS:
STREET 1: 1220 OLD ALPHARETTA RD
STREET 2: SUITE 300
CITY: ALPHARETTA
STATE: GA
ZIP: 30005
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RusnanoMedInvest LLC
CENTRAL INDEX KEY: 0001579466
STATE OF INCORPORATION: 1Z
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37783
FILM NUMBER: 161690543
BUSINESS ADDRESS:
STREET 1: SOKOLNICHESKYI VAL STR. OFFICE VII
CITY: MOSCOW
STATE: 1Z
ZIP: 107113 38
BUSINESS PHONE: 074955453912
MAIL ADDRESS:
STREET 1: SOKOLNICHESKYI VAL STR. OFFICE VII
CITY: MOSCOW
STATE: 1Z
ZIP: 107113 38
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RMI Investments S.a.r.l.
CENTRAL INDEX KEY: 0001579787
STATE OF INCORPORATION: 1Z
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37783
FILM NUMBER: 161690544
BUSINESS ADDRESS:
STREET 1: 17, RUE DES JARDINIERS
CITY: LUXEMBOURG
STATE: N4
ZIP: L-1835
BUSINESS PHONE: 79851530799
MAIL ADDRESS:
STREET 1: 7, ROBERT STUMPER
CITY: GRAND DUCHY
STATE: N4
ZIP: L-2557
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2016-06-01
0
0001539029
Clearside Biomedical, Inc.
CLSD
0001579787
RMI Investments S.a.r.l.
7, ROBERT STUMPER
GRAND DUCHY
N4
L-2557
LUXEMBOURG
0
0
1
0
0001579466
RusnanoMedInvest LLC
44, BLDG. 1, KRASNOBOGATYRSKAYA STREET
MOSCOW
1Z
107076
RUSSIAN FEDERATION
0
0
1
0
Common Stock
335769
D
Series B Preferred Stock
Common Stock
1179398
D
The number of shares of common stock reflects a 1-for-2.2 reverse stock split of the Issuer's common stock effected on May 11, 2016.
The Reporting Person is a wholly-owned subsidiary of Rusnano MedInvest LLC ("RMI LLC"). RMI LLC is the beneficiary of the Reporting Person.
Each share of the Series B Preferred Stock is convertible, at any time, at the holder's election, into 0.454545 shares of the Issuer's common stock. In addition, effective immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of Series B Preferred Stock will automatically convert into 0.454545 shares of the Issuer's common stock. The Series B Preferred Stock has no expiration date.
The number of underlying shares of common stock reflects a 1-for-2.2 reverse stock split of the Issuer's common stock effected on May 11, 2016.
/s/ Vladimir Gurdus, CEO of RMI Partners, LLC, Managing Company for Rusnano MedInvest, LLC, its Category A Manager
2016-06-01
/s/ Vladimir Gurdus, CEO of RMI Partners, LLC its Managing Company
2016-06-01